S100A9 and neoplasm: MDSC express receptors for S100A8 and S100A9, Wang et al. (2020) used CRISPR CAS9 to knock down specific immunosuppressive factors in a mouse tumor model and found that STAT3 has a significant role in controlling the differentiation of MDSCs.